English
简体中文
Total: £ 56.28
Published Date: 2024-04-10 | Pages: 92 | Tables: 185 | Chemical & Material
Fluorine-containing intermediates are chemical raw materials or chemical products used in the process of drug synthesis. Such chemical products can be produced in ordinary chemical plants without a drug production license. Can be used for the synthesis of drugs.
The global Fluorinated Pharmaceutical Intermediates market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Fluorinated Pharmaceutical Intermediates, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fluorinated Pharmaceutical Intermediates.
Report Scope
The Fluorinated Pharmaceutical Intermediates market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fluorinated Pharmaceutical Intermediates market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fluorinated Pharmaceutical Intermediates companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
Catalent
Patheon
BASF
Jubilant
Granules
Ganesh
Chemcon
Chemours
Zhejiang Yongtai Technology
Shenzhen Capchem Technology
Zhejiang Zhongxin Fluoride Materials
Jiangsu Feiyu Technology
Shanghai Sinofluoro
Shanghai Aqbiopharma
Hangzhou Fluoro Pharmaceutical
Zhejiang Dayang Biotech
Shandong Feiyuan Group
Segment by Type
Aromatic Fluoride
Aliphatic Fluoride
Segment by Application
Antiviral Drug
Anti-infectives Drug
Antirheumatic Drug
Antibacterial Drug
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fluorinated Pharmaceutical Intermediates companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fluorinated Pharmaceutical Intermediates Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Aromatic Fluoride
1.2.3 Aliphatic Fluoride
1.3 Market by Application
1.3.1 Global Fluorinated Pharmaceutical Intermediates Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Antiviral Drug
1.3.3 Anti-infectives Drug
1.3.4 Antirheumatic Drug
1.3.5 Antibacterial Drug
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Fluorinated Pharmaceutical Intermediates Market Perspective (2019-2030)
2.2 Fluorinated Pharmaceutical Intermediates Growth Trends by Region
2.2.1 Global Fluorinated Pharmaceutical Intermediates Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Fluorinated Pharmaceutical Intermediates Historic Market Size by Region (2019-2024)
2.2.3 Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Region (2025-2030)
2.3 Fluorinated Pharmaceutical Intermediates Market Dynamics
2.3.1 Fluorinated Pharmaceutical Intermediates Industry Trends
2.3.2 Fluorinated Pharmaceutical Intermediates Market Drivers
2.3.3 Fluorinated Pharmaceutical Intermediates Market Challenges
2.3.4 Fluorinated Pharmaceutical Intermediates Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fluorinated Pharmaceutical Intermediates Players by Revenue
3.1.1 Global Top Fluorinated Pharmaceutical Intermediates Players by Revenue (2019-2024)
3.1.2 Global Fluorinated Pharmaceutical Intermediates Revenue Market Share by Players (2019-2024)
3.2 Global Fluorinated Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Fluorinated Pharmaceutical Intermediates Revenue
3.4 Global Fluorinated Pharmaceutical Intermediates Market Concentration Ratio
3.4.1 Global Fluorinated Pharmaceutical Intermediates Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fluorinated Pharmaceutical Intermediates Revenue in 2023
3.5 Fluorinated Pharmaceutical Intermediates Key Players Head office and Area Served
3.6 Key Players Fluorinated Pharmaceutical Intermediates Product Solution and Service
3.7 Date of Enter into Fluorinated Pharmaceutical Intermediates Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fluorinated Pharmaceutical Intermediates Breakdown Data by Type
4.1 Global Fluorinated Pharmaceutical Intermediates Historic Market Size by Type (2019-2024)
4.2 Global Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Type (2025-2030)
5 Fluorinated Pharmaceutical Intermediates Breakdown Data by Application
5.1 Global Fluorinated Pharmaceutical Intermediates Historic Market Size by Application (2019-2024)
5.2 Global Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Fluorinated Pharmaceutical Intermediates Market Size (2019-2030)
6.2 North America Fluorinated Pharmaceutical Intermediates Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Fluorinated Pharmaceutical Intermediates Market Size by Country (2019-2024)
6.4 North America Fluorinated Pharmaceutical Intermediates Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Fluorinated Pharmaceutical Intermediates Market Size (2019-2030)
7.2 Europe Fluorinated Pharmaceutical Intermediates Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Fluorinated Pharmaceutical Intermediates Market Size by Country (2019-2024)
7.4 Europe Fluorinated Pharmaceutical Intermediates Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size (2019-2030)
8.2 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size by Region (2019-2024)
8.4 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Fluorinated Pharmaceutical Intermediates Market Size (2019-2030)
9.2 Latin America Fluorinated Pharmaceutical Intermediates Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Fluorinated Pharmaceutical Intermediates Market Size by Country (2019-2024)
9.4 Latin America Fluorinated Pharmaceutical Intermediates Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size (2019-2030)
10.2 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size by Country (2019-2024)
10.4 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Detail
11.1.2 Lonza Business Overview
11.1.3 Lonza Fluorinated Pharmaceutical Intermediates Introduction
11.1.4 Lonza Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
11.1.5 Lonza Recent Development
11.2 Catalent
11.2.1 Catalent Company Detail
11.2.2 Catalent Business Overview
11.2.3 Catalent Fluorinated Pharmaceutical Intermediates Introduction
11.2.4 Catalent Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
11.2.5 Catalent Recent Development
11.3 Patheon
11.3.1 Patheon Company Detail
11.3.2 Patheon Business Overview
11.3.3 Patheon Fluorinated Pharmaceutical Intermediates Introduction
11.3.4 Patheon Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
11.3.5 Patheon Recent Development
11.4 BASF
11.4.1 BASF Company Detail
11.4.2 BASF Business Overview
11.4.3 BASF Fluorinated Pharmaceutical Intermediates Introduction
11.4.4 BASF Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
11.4.5 BASF Recent Development
11.5 Jubilant
11.5.1 Jubilant Company Detail
11.5.2 Jubilant Business Overview
11.5.3 Jubilant Fluorinated Pharmaceutical Intermediates Introduction
11.5.4 Jubilant Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
11.5.5 Jubilant Recent Development
11.6 Granules
11.6.1 Granules Company Detail
11.6.2 Granules Business Overview
11.6.3 Granules Fluorinated Pharmaceutical Intermediates Introduction
11.6.4 Granules Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
11.6.5 Granules Recent Development
11.7 Ganesh
11.7.1 Ganesh Company Detail
11.7.2 Ganesh Business Overview
11.7.3 Ganesh Fluorinated Pharmaceutical Intermediates Introduction
11.7.4 Ganesh Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
11.7.5 Ganesh Recent Development
11.8 Chemcon
11.8.1 Chemcon Company Detail
11.8.2 Chemcon Business Overview
11.8.3 Chemcon Fluorinated Pharmaceutical Intermediates Introduction
11.8.4 Chemcon Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
11.8.5 Chemcon Recent Development
11.9 Chemours
11.9.1 Chemours Company Detail
11.9.2 Chemours Business Overview
11.9.3 Chemours Fluorinated Pharmaceutical Intermediates Introduction
11.9.4 Chemours Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
11.9.5 Chemours Recent Development
11.10 Zhejiang Yongtai Technology
11.10.1 Zhejiang Yongtai Technology Company Detail
11.10.2 Zhejiang Yongtai Technology Business Overview
11.10.3 Zhejiang Yongtai Technology Fluorinated Pharmaceutical Intermediates Introduction
11.10.4 Zhejiang Yongtai Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
11.10.5 Zhejiang Yongtai Technology Recent Development
11.11 Shenzhen Capchem Technology
11.11.1 Shenzhen Capchem Technology Company Detail
11.11.2 Shenzhen Capchem Technology Business Overview
11.11.3 Shenzhen Capchem Technology Fluorinated Pharmaceutical Intermediates Introduction
11.11.4 Shenzhen Capchem Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
11.11.5 Shenzhen Capchem Technology Recent Development
11.12 Zhejiang Zhongxin Fluoride Materials
11.12.1 Zhejiang Zhongxin Fluoride Materials Company Detail
11.12.2 Zhejiang Zhongxin Fluoride Materials Business Overview
11.12.3 Zhejiang Zhongxin Fluoride Materials Fluorinated Pharmaceutical Intermediates Introduction
11.12.4 Zhejiang Zhongxin Fluoride Materials Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
11.12.5 Zhejiang Zhongxin Fluoride Materials Recent Development
11.13 Jiangsu Feiyu Technology
11.13.1 Jiangsu Feiyu Technology Company Detail
11.13.2 Jiangsu Feiyu Technology Business Overview
11.13.3 Jiangsu Feiyu Technology Fluorinated Pharmaceutical Intermediates Introduction
11.13.4 Jiangsu Feiyu Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
11.13.5 Jiangsu Feiyu Technology Recent Development
11.14 Shanghai Sinofluoro
11.14.1 Shanghai Sinofluoro Company Detail
11.14.2 Shanghai Sinofluoro Business Overview
11.14.3 Shanghai Sinofluoro Fluorinated Pharmaceutical Intermediates Introduction
11.14.4 Shanghai Sinofluoro Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
11.14.5 Shanghai Sinofluoro Recent Development
11.15 Shanghai Aqbiopharma
11.15.1 Shanghai Aqbiopharma Company Detail
11.15.2 Shanghai Aqbiopharma Business Overview
11.15.3 Shanghai Aqbiopharma Fluorinated Pharmaceutical Intermediates Introduction
11.15.4 Shanghai Aqbiopharma Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
11.15.5 Shanghai Aqbiopharma Recent Development
11.16 Hangzhou Fluoro Pharmaceutical
11.16.1 Hangzhou Fluoro Pharmaceutical Company Detail
11.16.2 Hangzhou Fluoro Pharmaceutical Business Overview
11.16.3 Hangzhou Fluoro Pharmaceutical Fluorinated Pharmaceutical Intermediates Introduction
11.16.4 Hangzhou Fluoro Pharmaceutical Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
11.16.5 Hangzhou Fluoro Pharmaceutical Recent Development
11.17 Zhejiang Dayang Biotech
11.17.1 Zhejiang Dayang Biotech Company Detail
11.17.2 Zhejiang Dayang Biotech Business Overview
11.17.3 Zhejiang Dayang Biotech Fluorinated Pharmaceutical Intermediates Introduction
11.17.4 Zhejiang Dayang Biotech Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
11.17.5 Zhejiang Dayang Biotech Recent Development
11.18 Shandong Feiyuan Group
11.18.1 Shandong Feiyuan Group Company Detail
11.18.2 Shandong Feiyuan Group Business Overview
11.18.3 Shandong Feiyuan Group Fluorinated Pharmaceutical Intermediates Introduction
11.18.4 Shandong Feiyuan Group Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
11.18.5 Shandong Feiyuan Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Fluorinated Pharmaceutical Intermediates Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Aromatic Fluoride
Table 3. Key Players of Aliphatic Fluoride
Table 4. Global Fluorinated Pharmaceutical Intermediates Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Fluorinated Pharmaceutical Intermediates Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Fluorinated Pharmaceutical Intermediates Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Fluorinated Pharmaceutical Intermediates Market Share by Region (2019-2024)
Table 8. Global Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Fluorinated Pharmaceutical Intermediates Market Share by Region (2025-2030)
Table 10. Fluorinated Pharmaceutical Intermediates Market Trends
Table 11. Fluorinated Pharmaceutical Intermediates Market Drivers
Table 12. Fluorinated Pharmaceutical Intermediates Market Challenges
Table 13. Fluorinated Pharmaceutical Intermediates Market Restraints
Table 14. Global Fluorinated Pharmaceutical Intermediates Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Fluorinated Pharmaceutical Intermediates Market Share by Players (2019-2024)
Table 16. Global Top Fluorinated Pharmaceutical Intermediates Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fluorinated Pharmaceutical Intermediates as of 2023)
Table 17. Ranking of Global Top Fluorinated Pharmaceutical Intermediates Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Fluorinated Pharmaceutical Intermediates Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Fluorinated Pharmaceutical Intermediates Product Solution and Service
Table 21. Date of Enter into Fluorinated Pharmaceutical Intermediates Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Fluorinated Pharmaceutical Intermediates Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Fluorinated Pharmaceutical Intermediates Revenue Market Share by Type (2019-2024)
Table 25. Global Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Fluorinated Pharmaceutical Intermediates Revenue Market Share by Type (2025-2030)
Table 27. Global Fluorinated Pharmaceutical Intermediates Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Fluorinated Pharmaceutical Intermediates Revenue Market Share by Application (2019-2024)
Table 29. Global Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Fluorinated Pharmaceutical Intermediates Revenue Market Share by Application (2025-2030)
Table 31. North America Fluorinated Pharmaceutical Intermediates Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Fluorinated Pharmaceutical Intermediates Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Fluorinated Pharmaceutical Intermediates Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Fluorinated Pharmaceutical Intermediates Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Fluorinated Pharmaceutical Intermediates Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Fluorinated Pharmaceutical Intermediates Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Fluorinated Pharmaceutical Intermediates Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Fluorinated Pharmaceutical Intermediates Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Fluorinated Pharmaceutical Intermediates Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size by Country (2025-2030) & (US$ Million)
Table 46. Lonza Company Detail
Table 47. Lonza Business Overview
Table 48. Lonza Fluorinated Pharmaceutical Intermediates Product
Table 49. Lonza Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)
Table 50. Lonza Recent Development
Table 51. Catalent Company Detail
Table 52. Catalent Business Overview
Table 53. Catalent Fluorinated Pharmaceutical Intermediates Product
Table 54. Catalent Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)
Table 55. Catalent Recent Development
Table 56. Patheon Company Detail
Table 57. Patheon Business Overview
Table 58. Patheon Fluorinated Pharmaceutical Intermediates Product
Table 59. Patheon Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)
Table 60. Patheon Recent Development
Table 61. BASF Company Detail
Table 62. BASF Business Overview
Table 63. BASF Fluorinated Pharmaceutical Intermediates Product
Table 64. BASF Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)
Table 65. BASF Recent Development
Table 66. Jubilant Company Detail
Table 67. Jubilant Business Overview
Table 68. Jubilant Fluorinated Pharmaceutical Intermediates Product
Table 69. Jubilant Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)
Table 70. Jubilant Recent Development
Table 71. Granules Company Detail
Table 72. Granules Business Overview
Table 73. Granules Fluorinated Pharmaceutical Intermediates Product
Table 74. Granules Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)
Table 75. Granules Recent Development
Table 76. Ganesh Company Detail
Table 77. Ganesh Business Overview
Table 78. Ganesh Fluorinated Pharmaceutical Intermediates Product
Table 79. Ganesh Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)
Table 80. Ganesh Recent Development
Table 81. Chemcon Company Detail
Table 82. Chemcon Business Overview
Table 83. Chemcon Fluorinated Pharmaceutical Intermediates Product
Table 84. Chemcon Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)
Table 85. Chemcon Recent Development
Table 86. Chemours Company Detail
Table 87. Chemours Business Overview
Table 88. Chemours Fluorinated Pharmaceutical Intermediates Product
Table 89. Chemours Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)
Table 90. Chemours Recent Development
Table 91. Zhejiang Yongtai Technology Company Detail
Table 92. Zhejiang Yongtai Technology Business Overview
Table 93. Zhejiang Yongtai Technology Fluorinated Pharmaceutical Intermediates Product
Table 94. Zhejiang Yongtai Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)
Table 95. Zhejiang Yongtai Technology Recent Development
Table 96. Shenzhen Capchem Technology Company Detail
Table 97. Shenzhen Capchem Technology Business Overview
Table 98. Shenzhen Capchem Technology Fluorinated Pharmaceutical Intermediates Product
Table 99. Shenzhen Capchem Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)
Table 100. Shenzhen Capchem Technology Recent Development
Table 101. Zhejiang Zhongxin Fluoride Materials Company Detail
Table 102. Zhejiang Zhongxin Fluoride Materials Business Overview
Table 103. Zhejiang Zhongxin Fluoride Materials Fluorinated Pharmaceutical Intermediates Product
Table 104. Zhejiang Zhongxin Fluoride Materials Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)
Table 105. Zhejiang Zhongxin Fluoride Materials Recent Development
Table 106. Jiangsu Feiyu Technology Company Detail
Table 107. Jiangsu Feiyu Technology Business Overview
Table 108. Jiangsu Feiyu Technology Fluorinated Pharmaceutical Intermediates Product
Table 109. Jiangsu Feiyu Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)
Table 110. Jiangsu Feiyu Technology Recent Development
Table 111. Shanghai Sinofluoro Company Detail
Table 112. Shanghai Sinofluoro Business Overview
Table 113. Shanghai Sinofluoro Fluorinated Pharmaceutical Intermediates Product
Table 114. Shanghai Sinofluoro Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)
Table 115. Shanghai Sinofluoro Recent Development
Table 116. Shanghai Aqbiopharma Company Detail
Table 117. Shanghai Aqbiopharma Business Overview
Table 118. Shanghai Aqbiopharma Fluorinated Pharmaceutical Intermediates Product
Table 119. Shanghai Aqbiopharma Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)
Table 120. Shanghai Aqbiopharma Recent Development
Table 121. Hangzhou Fluoro Pharmaceutical Company Detail
Table 122. Hangzhou Fluoro Pharmaceutical Business Overview
Table 123. Hangzhou Fluoro Pharmaceutical Fluorinated Pharmaceutical Intermediates Product
Table 124. Hangzhou Fluoro Pharmaceutical Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)
Table 125. Hangzhou Fluoro Pharmaceutical Recent Development
Table 126. Zhejiang Dayang Biotech Company Detail
Table 127. Zhejiang Dayang Biotech Business Overview
Table 128. Zhejiang Dayang Biotech Fluorinated Pharmaceutical Intermediates Product
Table 129. Zhejiang Dayang Biotech Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)
Table 130. Zhejiang Dayang Biotech Recent Development
Table 131. Shandong Feiyuan Group Company Detail
Table 132. Shandong Feiyuan Group Business Overview
Table 133. Shandong Feiyuan Group Fluorinated Pharmaceutical Intermediates Product
Table 134. Shandong Feiyuan Group Revenue in Fluorinated Pharmaceutical Intermediates Business (2019-2024) & (US$ Million)
Table 135. Shandong Feiyuan Group Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Fluorinated Pharmaceutical Intermediates Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Fluorinated Pharmaceutical Intermediates Market Share by Type: 2023 VS 2030
Figure 3. Aromatic Fluoride Features
Figure 4. Aliphatic Fluoride Features
Figure 5. Global Fluorinated Pharmaceutical Intermediates Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Fluorinated Pharmaceutical Intermediates Market Share by Application: 2023 VS 2030
Figure 7. Antiviral Drug Case Studies
Figure 8. Anti-infectives Drug Case Studies
Figure 9. Antirheumatic Drug Case Studies
Figure 10. Antibacterial Drug Case Studies
Figure 11. Others Case Studies
Figure 12. Fluorinated Pharmaceutical Intermediates Report Years Considered
Figure 13. Global Fluorinated Pharmaceutical Intermediates Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Fluorinated Pharmaceutical Intermediates Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Fluorinated Pharmaceutical Intermediates Market Share by Region: 2023 VS 2030
Figure 16. Global Fluorinated Pharmaceutical Intermediates Market Share by Players in 2023
Figure 17. Global Top Fluorinated Pharmaceutical Intermediates Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fluorinated Pharmaceutical Intermediates as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Fluorinated Pharmaceutical Intermediates Revenue in 2023
Figure 19. North America Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Fluorinated Pharmaceutical Intermediates Market Share by Country (2019-2030)
Figure 21. United States Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Fluorinated Pharmaceutical Intermediates Market Share by Country (2019-2030)
Figure 25. Germany Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Share by Region (2019-2030)
Figure 33. China Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Fluorinated Pharmaceutical Intermediates Market Share by Country (2019-2030)
Figure 41. Mexico Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Share by Country (2019-2030)
Figure 45. Turkey Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Lonza Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
Figure 48. Catalent Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
Figure 49. Patheon Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
Figure 50. BASF Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
Figure 51. Jubilant Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
Figure 52. Granules Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
Figure 53. Ganesh Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
Figure 54. Chemcon Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
Figure 55. Chemours Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
Figure 56. Zhejiang Yongtai Technology Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
Figure 57. Shenzhen Capchem Technology Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
Figure 58. Zhejiang Zhongxin Fluoride Materials Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
Figure 59. Jiangsu Feiyu Technology Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
Figure 60. Shanghai Sinofluoro Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
Figure 61. Shanghai Aqbiopharma Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
Figure 62. Hangzhou Fluoro Pharmaceutical Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
Figure 63. Zhejiang Dayang Biotech Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
Figure 64. Shandong Feiyuan Group Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
